BioSpace News Archive

TARA Biosystems Inc. announced today the launch of Cardiotype.Fo, the best-in-class in vitro system for assessment of cardiac contractility.

GeoVax Labs, Inc. today is observing National Gay Men’s HIV/AIDS Awareness Day

CASH POSITION AT JUNE 30, 2018: €14.9 million

Without regard for clear Congressional intent, the United States Drug Enforcement Administration (DEA) continues to act contrary to the express authorizations provided for in Section 7606 of the Agricultural Act of 2014 (the “Farm Bill”) and the Ninth Circuit Court of Appeals’ order in HIA v. DEA III (April 2018).

Retrophin, Inc. today announced two upcoming presentations related to its development program for sparsentan in the treatment of IgA nephropathy

Updated data show continued reductions in body weight and decreased appetite in patients with rare genetic disorders of obesity

Motif Bio plc notes the announcement made today via RNS by Amphion Innovations plc that Amphion had reached an agreement in principle, subject to entering into a binding agreement, to extend the repayment of the loan facility by one year until 30 September 2019.

Interim results for the six months to 30 June 2018

Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all persons or entities who purchased or otherwise acquired Alnylam Pharmaceuticals, Inc. (ALNY) securities between February 15, 2018 through September 12, 2018 (the “Class Period”).

Gritstone Oncology, Inc. today announced the pricing of its initial public offering of 6,666,667 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts and commissions.